21 Recruiting Stargardt Disease Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Stargardt Disease
Top Recruiting Stargardt Disease Studies
An Observational Study in Children and Adults With Stargardt Disease
📍 Retina Foundation of the Southwest — Dallas, Texas
View Study & Checklist ➔Non-interventional Long Term Follow-up Study of Participants Previously Enrolled in the STARLIGHT Study
📍 Nanocope Clnical Site — Miami, Florida
View Study & Checklist ➔Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)
📍 Alkeus Site — Phoenix, Arizona
View Study & Checklist ➔A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease
📍 Associated Retina Consultants — Phoenix, Arizona
View Study & Checklist ➔Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease
📍 RayTx Clinical Site — Bakersfield, California
View Study & Checklist ➔Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
📍 University of San Francisco — San Francisco, California
View Study & Checklist ➔Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
📍 University of San Francisco — San Francisco, California
View Study & Checklist ➔A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions
📍 Associated Retina Consultants — Phoenix, Arizona
View Study & Checklist ➔A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
📍 Associated Retina Consultants — Phoenix, Arizona
View Study & Checklist ➔A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)
📍 Associated Retina Consultants — Phoenix, Arizona
View Study & Checklist ➔A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)
📍 UCHealth Sue Anschutz-Rodgers Eye Center, — Aurora, Colorado
View Study & Checklist ➔Study of ALK-001 on the Progression of Stargardt Disease
📍 Associated Retina Consultants — Phoenix, Arizona
View Study & Checklist ➔